Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
1951 • 319,299 citations
Beyond Cholesterol
1989 • 6,533 citations
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
1984 • 1,631 citations
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
1987 • 1,051 citations
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
1990 • 836 citations
Role of vitamin E in preventing the oxidation of low-density lipoprotein
1991 • 649 citations
Probucol inhibits oxidative modification of low density lipoprotein.
1986 • 633 citations
Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans
1991 • 323 citations
Safety of oral intake of vitamin E
1988 • 298 citations
Comparison of the efficiencies of several natural and synthetic antioxidants in aqueous SDS [sodium dodecyl sulfate] micelle solutions
1988 • 241 citations
Plasma Vitamins E and A Inversely Correlated to Mortality from Ischemic Heart Disease in Cross‐Cultural Epidemiology
1989 • 240 citations
Effects of probucol on xanthomata regression in familial hypercholesterolemia
1986 • 232 citations
Probucol
1989 • 161 citations
Probucol attenuates the development of aortic atherosclerosis in cholesterol‐fed rabbits
1989 • 142 citations
Vitamin E and other Lipophilic Antioxidants Protect LDL against Oxidation
1989 • 134 citations
Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.
1989 • 107 citations
Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B.
1986 • 92 citations
The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.
1983 • 78 citations
Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.
1991 • 73 citations
Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro
1990 • 62 citations
Prevention of atherosclerotic progression in Watanabe rabbits by probucol
1988 • 57 citations
Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay.
1988 • 39 citations
Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol
1988 • 32 citations
Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits.
1989 • 24 citations